Author

Ramesh P. Arasaradnam

Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition
Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition

Ramesh P. Arasaradnam  et al.

CORTICOSTEROID-SPARING EFFECTS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS THROUGH 4 YEARS: UNIFI LONG-TERM EXTENSION
CORTICOSTEROID-SPARING EFFECTS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS THROUGH 4 YEARS: UNIFI LONG-TERM EXTENSION

Ramesh P. Arasaradnam  et al.

CORTICOSTEROID-SPARING EFFECTS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS THROUGH 4 YEARS: UNIFI LONG-TERM EXTENSION
CORTICOSTEROID-SPARING EFFECTS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS THROUGH 4 YEARS: UNIFI LONG-TERM EXTENSION

URINARY VOLATILE ORGANIC COMPOUNDS IN COMPARISON TO ALPHA FETOPROTEIN (AFP) IN HEPATOCELLULAR CARCINOMA. AN EXPLORATORY STUDY
URINARY VOLATILE ORGANIC COMPOUNDS IN COMPARISON TO ALPHA FETOPROTEIN (AFP) IN HEPATOCELLULAR CARCINOMA. AN EXPLORATORY STUDY

Ramesh P. Arasaradnam  et al.

URINARY ANALYSIS OF HEPATOCELLULAR CARCINOMA PATIENTS USING SOLID PHASE MICROEXTRACTION
URINARY ANALYSIS OF HEPATOCELLULAR CARCINOMA PATIENTS USING SOLID PHASE MICROEXTRACTION

Ramesh P. Arasaradnam  et al.

PROFILING OF URINARY PEPTIDES IN HEPATOCELLULAR CARCINOMA: AN EXPLORATORY STUDY
PROFILING OF URINARY PEPTIDES IN HEPATOCELLULAR CARCINOMA: AN EXPLORATORY STUDY

Ramesh P. Arasaradnam  et al.

PROTON PUMP INHIBITORS AND FAECAL IMMUNOCHEMICAL TEST FOR THE DETECTION OF ADVANCED NEOPLASIA IN SYMPTOMATIC POPULATION
PROTON PUMP INHIBITORS AND FAECAL IMMUNOCHEMICAL TEST FOR THE DETECTION OF ADVANCED NEOPLASIA IN SYMPTOMATIC POPULATION

Ramesh P. Arasaradnam  et al.

EXTERNAL VALIDATION OF A FAECAL IMMUNOCHEMICAL TEST BASED-RISK SCORE FOR ADVANCED NEOPLASIA IN A BRITISH SYMPTOMATIC POPULATION
EXTERNAL VALIDATION OF A FAECAL IMMUNOCHEMICAL TEST BASED-RISK SCORE FOR ADVANCED NEOPLASIA IN A BRITISH SYMPTOMATIC POPULATION

Ramesh P. Arasaradnam  et al.

EFFICACY AND SAFETY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 4 YEARS: FINAL RESULTS FROM THE UNIFI LONG-TERM EXTENSION
EFFICACY AND SAFETY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 4 YEARS: FINAL RESULTS FROM THE UNIFI LONG-TERM EXTENSION

Ramesh P. Arasaradnam  et al.

GASTROINTESTINAL SYMPTOMS AND OUTCOMES OF HOSPITALISED SARS-COV-2 PATIENTS. A RETROSPECTIVE STUDY FROM A LARGE UNIVERSITY HOSPITAL IN THE WEST MIDLANDS, UK
GASTROINTESTINAL SYMPTOMS AND OUTCOMES OF HOSPITALISED SARS-COV-2 PATIENTS. A RETROSPECTIVE STUDY FROM A LARGE UNIVERSITY HOSPITAL IN THE WEST MIDLANDS, UK

Ramesh P. Arasaradnam  et al.

EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS IN PATIENTS THROUGH 3 YEARS: UNIFI LONG-TERM EXTENSION
EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS IN PATIENTS THROUGH 3 YEARS: UNIFI LONG-TERM EXTENSION

Ramesh P. Arasaradnam  et al.

Item 1 - 11 / 11
1